Advertisement

Cell Biology and Toxicology

, Volume 28, Issue 3, pp 125–131 | Cite as

Cytoplasmic vacuolization during exposure to drugs and other substances

  • Toshihiko Aki
  • Akina Nara
  • Koichi Uemura
Review Article

Abstract

Cytoplasmic vacuolization upon exposure to a variety of chemicals and bioactive substances has been extensively reported. Nearly 30 years have passed since the description by Nobel Laureate Christian de Duve of the mechanism underlying the lysosomal accumulation of lipophilic weak bases referred to these substances as lysosomotropic agents. It has now been revealed, however, that vacuolization occurs upon exposure to compounds other than lipophilic weak bases. Vacuolization of organelles/vesicles other than acidic compartments has also now been reported. In this mini-review, we provide an overview of the origin, mechanism, and possible outcomes of cellular vacuolization during exposure to substances with lysosomotropic as well as other properties.

Keywords

Autophagy Endocytosis ER stress Lysosome Lysosomotropicity Vacuolization 

References

  1. Belkin M, Hardy WG, Orr HC, Lachman AB. Induction in vitro by autonomic drugs of cytoplasmic vacuoles in ascites tumor cells. J Natl Cancer Inst. 1962;28:187–201.PubMedGoogle Scholar
  2. Cerny J, Feng Y, Yu A, Miyake K, Borgonovo B, Klumperman J, et al. The small chemical vacuolin-1 inhibits Ca(2+)-dependent lysosomal exocytosis but not cell resealing. EMBO Rep. 2004;5:883–8.PubMedCrossRefGoogle Scholar
  3. Chauhan D, Hideshima T, Mitsiades C, Richardson P, Anderson KC. Proteasome inhibitor therapy in multiple myeloma. Mol Cancer Ther. 2005;4:686–92.PubMedCrossRefGoogle Scholar
  4. Chen TS, Wang XP, Sun L, Wang LX, Xing D, Mok M. Taxol induces caspase-independent cytoplasmic vacuolization and cell death through endoplasmic reticulum (ER) swelling in ASTC-a-1 cells. Cancer Lett. 2008;270:164–72.PubMedCrossRefGoogle Scholar
  5. de Duve C, de Barsy T, Poole B, Trouet A, Tulkens P, Van Hoof F. Commentary. Lysosomotropic agents. Biochem Pharmacol. 1974;23:2495–531.PubMedCrossRefGoogle Scholar
  6. Ding WX, Ni HM, Yin XM. Absence of Bax switched MG132-induced apoptosis to non-apoptotic cell death that could be suppressed by transcriptional or translational inhibition. Apoptosis. 2007;12:2233–44.PubMedCrossRefGoogle Scholar
  7. Fedorko ME, Hirsch JG, Cohn ZA. Autophagic vacuoles produced in vitro. I. Studies on cultured macrophages exposed to chloroquine. J Cell Biol. 1968;38:377–91.PubMedCrossRefGoogle Scholar
  8. Guo B, Hembruff SL, Villeneuve DJ, Kirwan AF, Parissenti AM. Potent killing of paclitaxel- and doxorubicin-resistant breast cancer cells by calphostin C accompanied by cytoplasmic vacuolization. Breast Cancer Res Treat. 2003;82:125–41.PubMedCrossRefGoogle Scholar
  9. Han W, Li L, Qiu S, Lu Q, Pan Q, Gu Y, et al. Shikonin circumvents cancer drug resistance by induction of a necroptotic death. Mol Cancer Ther. 2007;6:1641–9.PubMedCrossRefGoogle Scholar
  10. Henics T, Wheatley DN. Cytoplasmic vacuolation, adaptation and cell death: a view on new perspectives and features. Biol Cell. 1999;91:485–98.PubMedCrossRefGoogle Scholar
  11. Hotchin NA, Cover TL, Akhtar N. Cell vacuolation induced by the VacA cytotoxin of Helicobacter pylori is regulated by the Rac1 GTPase. J Biol Chem. 2000;275:14009–12.PubMedCrossRefGoogle Scholar
  12. Johnson EE, Overmeyer JH, Gunning WT, Maltese WA. Gene silencing reveals a specific function of hVps34 phosphatidylinositol 3-kinase in late versus early endosomes. J Cell Sci. 2006;119:1219–32.PubMedCrossRefGoogle Scholar
  13. Kar R, Singha PK, Venkatachalam MA, Saikumar P. A novel role for MAP1 LC3 in nonautophagic cytoplasmic vacuolation death of cancer cells. Oncogene. 2009;28:2556–68.PubMedCrossRefGoogle Scholar
  14. Kaul A, Maltese WA. Killing of cancer cells by the photoactivatable protein kinase C inhibitor, calphostin C, involves induction of endoplasmic reticulum stress. Neoplasia. 2009;11:823–34.PubMedGoogle Scholar
  15. Koepsell H, Lips K, Volk C. Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res. 2007;24:1227–51.PubMedCrossRefGoogle Scholar
  16. Kroemer G, Jaattela M. Lysosomes and autophagy in cell death control. Nat Rev Cancer. 2005;5:886–97.PubMedCrossRefGoogle Scholar
  17. Kroemer G, Levine B. Autophagic cell death: the story of a misnomer. Nat Rev Mol Cell Biol. 2008;9:1004–10.PubMedCrossRefGoogle Scholar
  18. Li C, Macdonald JI, Hryciw T, Meakin SO. Nerve growth factor activation of the TrkA receptor induces cell death, by macropinocytosis, in medulloblastoma Daoy cells. J Neurochem. 2010;112:882–99.PubMedCrossRefGoogle Scholar
  19. Michalik M, Pierzchalska M, Pabianczyk-Kulka A, Korohoda W. Procaine-induced enhancement of fluid-phase endocytosis and inhibition of exocytosis in human skin fibroblasts. Eur J Pharmacol. 2003;475:1–10.PubMedCrossRefGoogle Scholar
  20. Mimnaugh EG, Xu W, Vos M, Yuan X, Isaacs JS, Bisht KS, et al. Simultaneous inhibition of hsp 90 and the proteasome promotes protein ubiquitination, causes endoplasmic reticulum-derived cytosolic vacuolization, and enhances antitumor activity. Mol Cancer Ther. 2004;3:551–66.PubMedGoogle Scholar
  21. Mimnaugh EG, Xu W, Vos M, Yuan X, Neckers L. Endoplasmic reticulum vacuolization and valosin-containing protein relocalization result from simultaneous hsp90 inhibition by geldanamycin and proteasome inhibition by velcade. Mol Cancer Res. 2006;4:667–81.PubMedCrossRefGoogle Scholar
  22. Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell. 2010;140:313–26.PubMedCrossRefGoogle Scholar
  23. Molinari M, Galli C, Norais N, Telford JL, Rappuoli R, Luzio JP, et al. Vacuoles induced by Helicobacter pylori toxin contain both late endosomal and lysosomal markers. J Biol Chem. 1997;272:25339–44.PubMedCrossRefGoogle Scholar
  24. Morissette G, Moreau E, Gaudreault RC, Marceau F. Massive cell vacuolization induced by organic amines such as procainamide. J Pharmacol Exp Ther. 2004;310:395–406.PubMedCrossRefGoogle Scholar
  25. Morissette G, Lodge R, Marceau F. Intense pseudotransport of a cationic drug mediated by vacuolar ATPase: procainamide-induced autophagic cell vacuolization. Toxicol Appl Pharmacol. 2008;228:364–77.PubMedCrossRefGoogle Scholar
  26. Nara A, Aki T, Funakoshi T, Uemura K. Methamphetamine induces macropinocytosis in differentiated SH-SY5Y human neuroblastoma cells. Brain Res. 2010;1352:1–10.PubMedCrossRefGoogle Scholar
  27. Ohkuma S, Poole B. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc Natl Acad Sci U S A. 1978;75:3327–31.PubMedCrossRefGoogle Scholar
  28. Ohkuma S, Poole B. Cytoplasmic vacuolation of mouse peritoneal macrophages and the uptake into lysosomes of weakly basic substances. J Cell Biol. 1981;90:656–64.PubMedCrossRefGoogle Scholar
  29. Overmeyer JH, Maltese WA. Death pathways triggered by activated Ras in cancer cells. Front Biosci. 2011;16:1693–713.PubMedCrossRefGoogle Scholar
  30. Overmeyer JH, Kaul A, Johnson EE, Maltese WA. Active ras triggers death in glioblastoma cells through hyperstimulation of macropinocytosis. Mol Cancer Res. 2008;6:965–77.PubMedCrossRefGoogle Scholar
  31. Overmeyer JH, Young AM, Bhanot H, Maltese WA. A chalcone-related small molecule that induces methuosis, a novel form of non-apoptotic cell death, in glioblastoma cells. Mol Cancer. 2011;10:69.PubMedCrossRefGoogle Scholar
  32. Paroutis P, Touret N, Grinstein S. The pH of the secretory pathway: measurement, determinants, and regulation. Physiology (Bethesda). 2004;19:207–15.CrossRefGoogle Scholar
  33. Poole B, Ohkuma S. Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages. J Cell Biol. 1981;90:665–9.PubMedCrossRefGoogle Scholar
  34. Reaves BJ, Bright NA, Mullock BM, Luzio JP. The effect of wortmannin on the localisation of lysosomal type I integral membrane glycoproteins suggests a role for phosphoinositide 3-kinase activity in regulating membrane traffic late in the endocytic pathway. J Cell Sci. 1996;109(Pt 4):749–62.PubMedGoogle Scholar
  35. Soboll S, Elbers R, Scholz R, Heldt HW. Subcellular distribution of di- and tricarboxylates and pH gradients in perfused rat liver. Hoppe Seylers Z Physiol Chem. 1980;361:69–76.PubMedCrossRefGoogle Scholar
  36. Sperandio S, de Belle I, Bredesen DE. An alternative, nonapoptotic form of programmed cell death. Proc Natl Acad Sci U S A. 2000;97:14376–81.PubMedCrossRefGoogle Scholar
  37. Swanson JA, Watts C. Macropinocytosis. Trends Cell Biol. 1995;5:424–8.PubMedCrossRefGoogle Scholar
  38. Taldone T, Gozman A, Maharaj R, Chiosis G. Targeting Hsp90: small-molecule inhibitors and their clinical development. Curr Opin Pharmacol. 2008;8:370–4.PubMedCrossRefGoogle Scholar
  39. Trump BF, Berezesky IK, Chang SH, Phelps PC. The pathways of cell death: oncosis, apoptosis, and necrosis. Toxicol Pathol. 1997;25:82–8.PubMedCrossRefGoogle Scholar
  40. Ustundag Y, Bronk SF, Gores GJ. Proteasome inhibition-induces endoplasmic reticulum dysfunction and cell death of human cholangiocarcinoma cells. World J Gastroenterol. 2007;13:851–7.PubMedGoogle Scholar
  41. Wagenknecht B, Hermisson M, Groscurth P, Liston P, Krammer PH, Weller M. Proteasome inhibitor-induced apoptosis of glioma cells involves the processing of multiple caspases and cytochrome c release. J Neurochem. 2000;75:2288–97.PubMedCrossRefGoogle Scholar
  42. Willhite DC, Cover TL, Blanke SR. Cellular vacuolation and mitochondrial cytochrome c release are independent outcomes of Helicobacter pylori vacuolating cytotoxin activity that are each dependent on membrane channel formation. J Biol Chem. 2003;278:48204–9.PubMedCrossRefGoogle Scholar
  43. Yamasaki E, Wada A, Kumatori A, Nakagawa I, Funao J, Nakayama M, et al. Helicobacter pylori vacuolating cytotoxin induces activation of the proapoptotic proteins Bax and Bak, leading to cytochrome c release and cell death, independent of vacuolation. J Biol Chem. 2006;281:11250–9.PubMedCrossRefGoogle Scholar
  44. Yang WC, Strasser FF, Pomerat CM. Mechanism of drug-induced vacuolization in tissue culture. Exp Cell Res. 1965;38:495–506.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  1. 1.Section of Forensic Medicine, Graduate School of Medical and Dental SciencesTokyo Medical and Dental UniversityBunkyo-kuJapan

Personalised recommendations